SEVERE INTRAOCULAR PRESSURE ELEVATION FOLLOWING INTRAVITREAL RANIBIZUMAB (LUCENTIS) INJECTION FOR WET AGE-RELATED MACULAR DEGENERATION

被引：0
|
作者：
Reis, Gustavo [1 ]
Schendel, Steven [1 ]
Goldberg, Ivan [1 ,2 ]
Lim, Ridia [1 ,2 ]
Chua, Brian E. [1 ,2 ,3 ]
Lee, Anne [1 ,2 ]
Martins, Alessandra [1 ,2 ]
Higgins, Ralph [1 ,2 ]
Grigg, John [1 ,2 ,4 ]
Clement, Colin I. [1 ,2 ]
机构：
[1] Sydney Eye Hosp, Glaucoma Unit, Sydney, NSW 2000, Australia
[2] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia
[3] Macquarie Univ, Sch Adv Med, Sydney, NSW 2109, Australia
[4] Save Sight Inst, Sydney, NSW 2000, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2013年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Endothelial cells analysis after intravitreal ranibizumab (Lucentis) in age-related macular degeneration treatment: a pilot study
    Perez-Rico, Consuelo
    Benitez-Herreros, Javier
    Castro-Rebollo, Maria
    Gomez-SanGil, Yanira
    Germain, Francisco
    Angeles Montes-Mollon, Maria
    Angel Teus, Miguel
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (02) : 267 - 268
  • [22] Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration
    Landa, Gennady
    Amde, Wendewessen
    Doshi, Vatsal
    Ali, Amro
    McGevna, Laura
    Gentile, Ronald C.
    Muldoon, Thomas O.
    Walsh, Joseph B.
    Rosen, Richard B.
    OPHTHALMOLOGICA, 2009, 223 (06) : 370 - 375
  • [23] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    Tan, C. S. H.
    EYE, 2011, 25 (10) : 1374 - 1374
  • [24] Esophageal Ulcer After Intravitreal Ranibizumab Injection in a Patient With Age-Related Macular Degeneration
    Li, Xin Qing
    Zhu, Ke Wei
    Lai, Jun
    Wu, Jian
    Guo, Xiao Fang
    GASTROENTEROLOGY RESEARCH, 2023, 16 (02) : 118 - 124
  • [25] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    C S H Tan
    Eye, 2011, 25 : 1374 - 1374
  • [26] First-Year Outcomes of Cataract Surgery Combined with Intravitreal Ranibizumab Injection in Wet Age-Related Macular Degeneration
    Sul, Sabahattin
    Karalezli, Aylin
    Karabulut, Mujdat
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2019, 49 (01): : 15 - 19
  • [27] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
  • [28] Incidence of elevated intraocular pressure after intravitreal injection in Japanese patients with age-related macular degeneration
    Maiko Maruyama-Inoue
    Tatsuya Inoue
    Shaheeda Mohamed
    Yoko Kitajima
    Shoko Ikeda
    Arisa Ito
    Kazuaki Kadonosono
    Scientific Reports, 11
  • [29] Incidence of elevated intraocular pressure after intravitreal injection in Japanese patients with age-related macular degeneration
    Maruyama-Inoue, Maiko
    Inoue, Tatsuya
    Mohamed, Shaheeda
    Kitajima, Yoko
    Ikeda, Shoko
    Ito, Arisa
    Kadonosono, Kazuaki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Do Intravitreal Ranibizumab Injections for Wet Age-Related Macular Degeneration Affect the Vitreomacular Interface?
    Sreekantam, S.
    Gibson, J. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345